Preoperative intra-aortic balloon pump inserted in acute myocardial infarction patients without cardiogenic shock

Feng Yang1, Liangshan Wang1, Dengbang Hou1

  • 1Center for Cardiac Intensive Care, Beijing Institute of Heart, Lung and Blood Vessel Diseases, Beijing Anzhen Hospital, Capital Medical University, Beijing, China.

Perfusion
|August 8, 2019
PubMed

Insights

Preoperative intra-aortic balloon pump use in acute myocardial infarction patients undergoing off-pump coronary artery bypass grafting did not improve survival. However, it did lead to shorter hospital stays, suggesting improved convalescence.

Area of Science:

  • Cardiology
  • Cardiac Surgery
  • Vascular Surgery

Background:

  • The utility of preoperative intra-aortic balloon pump (IABP) in high-risk cardiac surgery remains debated.
  • The specific role of preoperative IABP in acute myocardial infarction (AMI) patients without cardiogenic shock undergoing off-pump coronary artery bypass grafting (OPCABG) is not well-defined.

Purpose of the Study:

  • To evaluate the efficacy and safety of preoperative IABP insertion in patients with AMI without cardiogenic shock undergoing OPCABG.

Main Methods:

  • A retrospective observational study analyzed 421 consecutive AMI patients without cardiogenic shock who underwent isolated OPCABG.
  • Propensity score matching created 99 pairs comparing patients who received preoperative IABP (n=157) versus those who did not (control group, n=264).
  • Outcomes assessed included 30-day postoperative survival, complications, and hospital length of stay.

Main Results:

  • Preoperative IABP did not significantly improve 30-day postoperative survival (HR 0.9; 95% CI 0.2-4.2; P=0.92).
  • Patients receiving preoperative IABP experienced significantly shorter postoperative lengths of stay (8 vs. 10 days, P=0.02).
  • Total hospital days were also decreased in the IABP group (18.2 vs. 21.8 days, P=0.02).

Conclusions:

  • Preoperative IABP insertion in AMI patients without cardiogenic shock undergoing OPCABG does not enhance survival.
  • However, preoperative IABP use is associated with improved convalescence, evidenced by significantly shorter hospital stays.
Abstract

Related Concept Videos

Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
868
Acute Coronary Syndrome V: Nursing Management01:26

Acute Coronary Syndrome V: Nursing Management

Nursing Assessment:Nursing management of acute coronary syndrome (ACS) involves taking the patient's history, focusing on primary complaints such as chest pain, dyspnea, and excessive sweating (diaphoresis), as well as other symptoms like back or jaw pain, nausea, vomiting, palpitations, dizziness, and fatigue. The nurse also reviews the patient's history of cardiac events, risk factors such as hypertension, diabetes, smoking, family history, and current medications.In the objective assessment,...
283
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations01:19

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations

The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
372
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
222
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
230
ATP Driven Pumps III: V-type Pumps01:30

ATP Driven Pumps III: V-type Pumps

V-type pumps are ATP-driven pumps found in the vacuolar membranes of plants, yeast, endosomal and lysosomal membranes of animal cells, plasma membranes of a few specialized eukaryotic cells, and some prokaryotes. They are also known as the V1Vo-ATPase, that couple ATP hydrolysis to transport protons against a concentration gradient.
The peripheral or cytosolic V1 domain with eight subunits is involved in ATP hydrolysis. The integral or transmembrane V0 domain containing at least five subunits...
4.7K